glp-1 agonists vision loss blindness Zepbound Lawsuit [2026 Update] GLP-1 Medications and Your Vision:

doi: 10.1097/MOL.0000000000000750

However, significant variations in control types (placebo, MET, or intensive lifestyle), concomitant medications, and follow-up windows mean that a robust head-to-head ranking of strategies is still lacking

The second tier, represented by Bader et al

While the entry of generics could lower prices and possibly increase market penetration, large capex requirements for their manufacture may ultimately restrict the overall impact on supply

If you already have asymptomatic gallstones and are starting GLP-1 therapy This is one of the highest-risk situations and one of the most under-discussed